SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-14-005934
Filing Date
2014-11-10
Accepted
2014-11-10 16:15:43
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctix_10q.htm 10-Q 424312
2 CERTIFICATION ctix_311.htm EX-31.1 9990
3 CERTIFICATION ctix_312.htm EX-31.2 9885
4 CERTIFICATION ctix_321.htm EX-32.1 2913
5 CERTIFICATION ctix_322.htm EX-32.2 2798
  Complete submission text file 0001477932-14-005934.txt   3285415

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctix-20140930.xml EX-101.INS 356661
7 XBRL TAXONOMY EXTENSION SCHEMA ctix-20140930.xsd EX-101.SCH 53150
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctix-20140930_cal.xml EX-101.CAL 51020
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctix-20140930_def.xml EX-101.DEF 134890
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctix-20140930_lab.xml EX-101.LAB 276691
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctix-20140930_pre.xml EX-101.PRE 199079
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-52321 | Film No.: 141208847
SIC: 2834 Pharmaceutical Preparations